Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nobuyasu Shindo"'
Autor:
Tomomi Fujisawa, Yoshihiro Kamada, Hiromi Rakugi, Hiroshi Ikegami, Nobuyasu Shindo, Satomi Minato, Mina Hamano, Mitsuru Ohishi, Ken Sugimoto, Xiang Wang
Publikováno v:
Hepatology Research. 44:102-113
Aim Several studies using experimental non-alcoholic fatty liver disease (NAFLD) models have shown that ezetimibe, an inhibitor of cholesterol absorption mainly in the intestine, not only protects against diet-induced hyperlipidemia, but also attenua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::629b743e310d78b868725709aa218ce0
https://doi.org/10.1111/hepr.12092
https://doi.org/10.1111/hepr.12092
Autor:
Nobuyasu Shindo, Tomomi Fujisawa, Hiroshi Ikegami, Osamu Yasuda, Koji Nojima, Aya Oze-Fukai, Hiromi Rakugi, Xiang Wang, Ken Sugimoto, Yuki Yoshikawa
Publikováno v:
Journal of Hepatology. 52:903-912
Background & Aims Nonalcoholic fatty liver disease (NAFLD) is currently recognized as a global health issue and encompasses a wide spectrum of entities, ranging from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH). The lack of a spont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56a74117f49a6391b365ff77a8c91e38
https://doi.org/10.1016/j.jhep.2009.12.033
https://doi.org/10.1016/j.jhep.2009.12.033
Autor:
Yoshifumi Sato, Nobuyasu Shindo, Ken Sugimoto, Hiroshi Ikegami, Koji Nojima, Satomi Shimoyoshi, Tomomi Fujisawa, Yuki Yoshikawa, Hiromi Rakugi, I. Shimomura, Aya Oze-Fukai
Publikováno v:
Endocrine Journal. 56:227-234
Given the potential for beta-cells to increase their mass, glucose intolerance might be ameliorated by a compensatory increase in beta-cell mass. However, it remains uncertain whether such amelioration is feasible in vivo. In this study, we investiga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5cfd6617183db742dcd1dbf39aed855
https://doi.org/10.1507/endocrj.k08e-315
https://doi.org/10.1507/endocrj.k08e-315
Autor:
Katsuaki Asano, Nobuyasu Shindo, Tomomi Fujisawa, Toshio Ogihara, Yumiko Kawabata, Yoshihisa Hiromine, Hiroshi Ikegami, Aya Fukai, Shinsuke Noso, Koji Nojima
Publikováno v:
Diabetes Research and Clinical Practice. 77:S82-S86
A recent dramatic increase in elderly patients with diabetes mellitus has made the proper management of the disease in this population more important. Here, we discuss the present status of diabetes management in the elderly in Japan. As a characteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca76883e7a649ed8e503aca3102e8258
https://doi.org/10.1016/j.diabres.2007.01.038
https://doi.org/10.1016/j.diabres.2007.01.038
Autor:
Xiang, Wang, Ken, Sugimoto, Tomomi, Fujisawa, Nobuyasu, Shindo, Satomi, Minato, Yoshihiro, Kamada, Mina, Hamano, Mitsuru, Ohishi, Hiroshi, Ikegami, Hiromi, Rakugi
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 44(1)
Several studies using experimental non-alcoholic fatty liver disease (NAFLD) models have shown that ezetimibe, an inhibitor of cholesterol absorption mainly in the intestine, not only protects against diet-induced hyperlipidemia, but also attenuates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::df01a28420852061bdcc5055f0005114
https://pubmed.ncbi.nlm.nih.gov/23510093
https://pubmed.ncbi.nlm.nih.gov/23510093